Clinical trials for Myeloproliferative neoplasm
34 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT07441694Study of INCA036978 in Participants With Myeloproliferative NeoplasmsIncyte Corporation · PI: Incyte Medical Monitor
- RECRUITINGPhase 2NCT07148947Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative NeoplasmsUniversity of Washington · PI: Anna Halpern, MD
- RECRUITINGPhase 2NCT07228624Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap SyndromesFred Hutchinson Cancer Center · PI: Rachel Salit, MD
- RECRUITINGN/ANCT07119970Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)University Hospital, Bordeaux · PI: Alexandre GUY
- RECRUITINGPhase 2NCT06661915A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)National Cancer Institute (NCI) · PI: Anand A Patel
- RECRUITINGPhase 3NCT06468033P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 RiskPharmaEssentia · PI: Toshiaki Sato, MD/PhD
- RECRUITINGN/ANCT05745285Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and CareUniversity of Miami · PI: Frank Penedo, PhD
- RECRUITINGNCT06480591Evaluation of the Pathobiology of CALR-mutated MPN CellsWake Forest University Health Sciences · PI: Aleksander Chojecki, MD
- RECRUITINGPhase 3NCT06740916Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients with Aspirin ResistanceSiriraj Hospital
- ACTIVE NOT RECRUITINGNCT06553638Evaluation of the Prognostic Impact of Decreased Serum beta2 Microglobulin in the First Year of Follow-up of Myeloproliferative Neoplasia (PRODIGE)University Hospital, Brest
- ACTIVE NOT RECRUITINGNCT06481332Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis (CASTETTE)University Hospital, Brest
- ACTIVE NOT RECRUITINGNCT06476535Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory ImmunotherapyUniversity Hospital, Brest
- RECRUITINGNCT06462664Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)University Hospital, Brest
- RECRUITINGN/ANCT05842603I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm PatientsMassachusetts General Hospital · PI: Gabriela Hobbs, MD
- RECRUITINGNCT06022328Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC)University Hospital, Bordeaux
- RECRUITINGPhase 2NCT05074355Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative NeoplasmsUniversity Health Network, Toronto · PI: Vikas Gupta, M.D.
- RECRUITINGPhase 1NCT05936359A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmsIncyte Corporation · PI: Incyte Medical Monitor
- RECRUITINGNCT05839717Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)University Hospital, Bordeaux
- RECRUITINGPhase 2NCT05884333Cord Blood Transplant in Adults With Blood CancersMemorial Sloan Kettering Cancer Center · PI: Ann Jakubowski, MD
- RECRUITINGNCT06715267Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)University Hospital, Brest
- RECRUITINGNCT05850273Mechanism of Action of Interferon in the Treatment of Myeloproliferative NeoplasmsInstitut National de la Santé Et de la Recherche Médicale, France · PI: Florence Pasquier, MD,PhD
- RECRUITINGPhase 2NCT05732961Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN NeoplasmsH. Lee Moffitt Cancer Center and Research Institute · PI: Rami Komrokji, MD
- RECRUITINGNCT07410247MPN Childhood RegistryUniversity of Erlangen-Nürnberg Medical School · PI: Axel Karow, MD
- RECRUITINGNCT07204392Unveiling the Germline Predisposition to Myeloproliferative NeoplasmsFondazione IRCCS Policlinico San Matteo di Pavia
- ACTIVE NOT RECRUITINGNCT07204366Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)Fondazione IRCCS Policlinico San Matteo di Pavia
- RECRUITINGN/ANCT04898790Improving Cognitive Function in Older Adults Undergoing Stem Cell TransplantUniversity of Nebraska · PI: Thuy Koll, MD
- RECRUITINGPHASE1, PHASE2NCT04771130A Study of BGB-11417 in Participants With Myeloid MalignanciesBeiGene
- ACTIVE NOT RECRUITINGPhase 1NCT04250051Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid LeukemiaNorthwestern University · PI: Shira N Dinner, M.D.
- ACTIVE NOT RECRUITINGNCT04378855Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).Gruppo Italiano Malattie EMatologiche dell'Adulto
- ACTIVE NOT RECRUITINGPhase 1NCT04041050A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmAbbVie · PI: ABBVIE INC.
- ACTIVE NOT RECRUITINGNCT03618485Registry of Patients With MPNs in TaiwanChang Gung Memorial Hospital
- ACTIVE NOT RECRUITINGPhase 2NCT01761968Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative NeoplasmsItalfarmaco · PI: Alessandro Rambaldi, MD
- RECRUITINGNCT009350903'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerBarbara Ann Karmanos Cancer Institute · PI: Anthony F. Shields, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT00544115Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical Center · PI: Auayporn P. Nademanee, MD